The U.S.A. as represented by the Secretary; Department of Health and Human Services
发明人:
申请号：
EP11731200.9
公开号：
EP2585057B1
申请日:
2011.06.24
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The use of sterculic acid, and the pharmaceutically acceptable salt forms thereof, described for the treatment of inflammation, in particular, 7-ketocholesterol induced inflammation, 7-ketocholesterol toxicity, and unregulated angiogenesis.
